Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Table 2 Baseline demographic characteristics of subjects

Variable	NAOs group (n = 42)	Placebo group (n = 42)	Total (n = 84)	p-value¹⁾
Sex (M/F)	0/42	0/42	0/84
Age (years)	36.405 ± 10.258	37.405 ± 9.515	36.905 ± 9.847	0.645
Height (cm)	160.000 ± 5.622	162.071 ± 6.264	161.036 ± 6.007	0.115
Weight (kg)	67.436 ± 6.917	68.690 ± 7.578	68.063 ± 7.239	0.430
BMI (kg/m²)	26.324 ± 2.139	25.963 ± 1.874	26.146 ± 2.009	0.417
PBF (%)	36.933 ± 3.809	36.533 ± 3.243	36.733 ± 3.522	0.606
SBP (mmHg)	122.810 ± 10.530	119.786 ± 9.473	121.298 ± 10.071	0.170
DBP (mmHg)	75.476 ± 9.505	73.214 ± 9.188	74.345 ± 9.361	0.271
Pulse (beats/minute)	78.833 ± 10.329	76.452 ± 8.746	77.643 ± 9.587	0.258
TSH (µIU/mL)	2.148 ± 0.806	2.362 ± 1.050	2.255 ± 0.936	0.297
Alcohol (n, %)	22 (52.38)	17 (40.48)	39 (46.43)	0.274²⁾
Alcohol (units/week)	5.173 ± 5.328	3.371 ± 2.310	4.387 ± 4.331	0.165
Smoking (n, %)	0 (0.00)	0 (0.00)	0 (0.00)

NAOs, Neoagaro-oligosaccharides; BMI, body mass index; PBF, percent body fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; TSH, thyroid-stimulating hormone
Values are presented as mean ± SD or number (%)
¹⁾ Analyzed by independent t-test between the groups
²⁾ Analyzed by chi-square test between the groups

ISSN: 2662-7671